Clinical Trials Logo

Epilepsy clinical trials

View clinical trials related to Epilepsy.

Filter by:
  • Suspended  
  • Page 1

NCT ID: NCT05975931 Suspended - Epilepsy Clinical Trials

IMPACT of AspireSR® for VNS Therapy on Healthcare Resource Utilisation and Clinical Outcomes.

IMPACT
Start date: January 20, 2022
Phase:
Study type: Observational

This is a retrospective non-interventional study to describe the HCRU and clinical outcomes before and after AspireSR® device implantation in subjects with drug resistant epilepsy at the Queen Elizabeth Hospital, Birmingham (QEHB).

NCT ID: NCT04193891 Suspended - Epilepsy Clinical Trials

The Effect of Ketogenic Dietary Therapy on Sleep in Adult Epilepsy

Start date: February 12, 2020
Phase:
Study type: Observational

The modified Atkins diet, a form of ketogenic therapy in which individuals severely restrict their carbohydrate intake and subsequently enter ketosis, has begun to be used as an adjunctive treatment in adults with intractable epilepsy who are not surgical candidates. In this study, the investigators examine the effect of ketogenic dietary therapy on sleep, as sleep deprivation is one of the most common seizure triggers and seizures themselves have been found to affect sleep quality. This pilot study will enroll twenty participants, ten of whom are initiating ketogenic dietary therapy and ten participants who are being treated with standard anti-seizure drug therapy.

NCT ID: NCT02011971 Suspended - Epilepsy Clinical Trials

Cognitive Effects of Vinpocetine in Healthy Adults and Patients With Epilepsy

Start date: February 2012
Phase: Phase 1/Phase 2
Study type: Interventional

Pilot studies in healthy volunteers and in patients with epilepsy to assess the potential efficacy and safety of different dosages of vinpocetine in improving cognition.

NCT ID: NCT01744275 Suspended - Epilepsy Clinical Trials

HOPE-Epilepsy Trial

HOPE-Epilepsy
Start date: July 2013
Phase: Phase 2/Phase 3
Study type: Interventional

This a multi-center study to examine whether supplementation with omega 3 fatty acids will reduce seizure frequency in patients with epilepsy .